Sep 24, 2019

The Food and Drug Administration is again expanding its recall of widely prescribed blood pressure drugs due to contamination with a cancer-linked chemical.

Monday’s announcement targets an additional five lots of the generic drug losartan made by Torrent Pharmaceuticals Limited. The lots include losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets.

The recalled lots contain trace amounts of N-methylnitrosobutyric acid, or NMBA, which has been linked to cancer.